Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 52


Comparative effectiveness of immunosuppressive drugs and corticosteroids for lupus nephritis: a systematic review and network meta-analysis.

Singh JA, Hossain A, Kotb A, Wells GA.

Syst Rev. 2016 Sep 13;5(1):155. doi: 10.1186/s13643-016-0328-z.


Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany.

Plöthner M, Ribbentrop D, Hartman JP, Frank M.

Adv Ther. 2016 Sep;33(9):1461-80. doi: 10.1007/s12325-016-0376-8. Epub 2016 Jul 12. Review.


Therapeutic approach to IgG4-related disease: A systematic review.

Brito-Zerón P, Kostov B, Bosch X, Acar-Denizli N, Ramos-Casals M, Stone JH.

Medicine (Baltimore). 2016 Jun;95(26):e4002. doi: 10.1097/MD.0000000000004002.


Is Systemic Lupus Erythematosus Associated With a Declined Immunogenicity and Poor Safety of Influenza Vaccination?: A Systematic Review and Meta-Analysis.

Huang Y, Wang H, Wan L, Lu X, Tam WW.

Medicine (Baltimore). 2016 May;95(19):e3637. doi: 10.1097/MD.0000000000003637.


IgG4-related disease: a systematic review of this unrecognized disease in pediatrics.

Karim F, Loeffen J, Bramer W, Westenberg L, Verdijk R, van Hagen M, van Laar J.

Pediatr Rheumatol Online J. 2016 Mar 25;14(1):18. doi: 10.1186/s12969-016-0079-3. Review.


Treatment of idiopathic pulmonary fibrosis: a network meta-analysis.

Rochwerg B, Neupane B, Zhang Y, Garcia CC, Raghu G, Richeldi L, Brozek J, Beyene J, Schünemann H.

BMC Med. 2016 Feb 3;14:18. doi: 10.1186/s12916-016-0558-x.


Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives.

Magro-Checa C, Zirkzee EJ, Huizinga TW, Steup-Beekman GM.

Drugs. 2016 Mar;76(4):459-83. doi: 10.1007/s40265-015-0534-3. Review.


Association between Thiopurine S-Methyltransferase Polymorphisms and Azathioprine-Induced Adverse Drug Reactions in Patients with Autoimmune Diseases: A Meta-Analysis.

Liu YP, Xu HQ, Li M, Yang X, Yu S, Fu WL, Huang Q.

PLoS One. 2015 Dec 3;10(12):e0144234. doi: 10.1371/journal.pone.0144234. eCollection 2015.


Cardiovascular involvement in inflammatory bowel disease: Dangerous liaisons.

Filimon AM, Negreanu L, Doca M, Ciobanu A, Preda CM, Vinereanu D.

World J Gastroenterol. 2015 Sep 7;21(33):9688-92. doi: 10.3748/wjg.v21.i33.9688. Review.


Immunosuppressive Medications.

Wiseman AC.

Clin J Am Soc Nephrol. 2016 Feb 5;11(2):332-43. doi: 10.2215/CJN.08570814. Epub 2015 Jul 13.


The Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet): diagnostic and adjudication processes.

de Andrade J, Schwarz M, Collard HR, Gentry-Bumpass T, Colby T, Lynch D, Kaner RJ; IPFnet Investigators.

Chest. 2015 Oct;148(4):1034-42. doi: 10.1378/chest.14-2889.


Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysis.

Zhu GQ, Huang S, Huang GQ, Wang LR, Lin YQ, Wu YM, Shi KQ, Wang JT, Zhou ZR, Braddock M, Chen YP, Zhou MT, Zheng MH.

Oncotarget. 2015 Sep 15;6(27):24533-49. Review.


Effects of immunosuppressants on immune response to vaccine in inflammatory bowel disease.

Cao Y, Zhao D, Xu AT, Shen J, Ran ZH.

Chin Med J (Engl). 2015 Mar 20;128(6):835-8. doi: 10.4103/0366-6999.152683. Review.


The effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: systematic review, network meta-analysis and health economic evaluation.

Loveman E, Copley VR, Colquitt JL, Scott DA, Clegg AJ, Jones J, O'Reilly KM, Singh S, Bausewein C, Wells A.

BMC Pharmacol Toxicol. 2014 Nov 19;15:63. doi: 10.1186/2050-6511-15-63. Review.


Canadian Association of Gastroenterology position statement regarding the use of thiopurines for the treatment of inflammatory bowel disease.

Marshall JK, Otley AR, Afif W, Bernstein CN, Hookey L, Leontiadis G, Panaccione R, Bressler B, Canadian Association of Gastroenterology.

Can J Gastroenterol Hepatol. 2014 Jul-Aug;28(7):371-2. No abstract available.


Association between orofacial granulomatosis and Crohn's disease in children: systematic review.

Lazzerini M, Bramuzzo M, Ventura A.

World J Gastroenterol. 2014 Jun 21;20(23):7497-504. doi: 10.3748/wjg.v20.i23.7497. Review.


Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents.

Sidbury R, Davis DM, Cohen DE, Cordoro KM, Berger TG, Bergman JN, Chamlin SL, Cooper KD, Feldman SR, Hanifin JM, Krol A, Margolis DJ, Paller AS, Schwarzenberger K, Silverman RA, Simpson EL, Tom WL, Williams HC, Elmets CA, Block J, Harrod CG, Begolka WS, Eichenfield LF; American Academy of Dermatology.

J Am Acad Dermatol. 2014 Aug;71(2):327-49. doi: 10.1016/j.jaad.2014.03.030. Epub 2014 May 9.


Use of thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel diseases: a meta-analysis.

Gong J, Zhu L, Guo Z, Li Y, Zhu W, Li N, Li J.

PLoS One. 2013 Nov 28;8(11):e81487. doi: 10.1371/journal.pone.0081487. eCollection 2013.

Items per page

Supplemental Content

Loading ...
Support Center